About the Company
codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CDXS News
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ...
Codexis: Q4 Earnings Snapshot
REDWOOD CITY, Calif. — REDWOOD CITY, Calif. — Codexis Inc. (CDXS) on Wednesday reported a loss of $7.2 million in its fourth quarter. The Redwood City, California-based company said it had a ...
Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript
Welcome to the Codexis Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please note that this call is being recorded. And now I'll turn the call over to Carrie ...
Codexis Inc
*Each quarterly filing is treated as a separate report. Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, ...
Codexis, Inc. (CDXS) latest stock news & headlines – Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript February 28, 2024 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16. CDXS isn’t one of the 30 most ...
Codexis, Inc. (0I0X.L)
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive ...
Codexis, Inc.: Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Feb. 28, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ended December 31 ...
Loading the latest forecasts...